Patents by Inventor Véronique Monjardet

Véronique Monjardet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • URANIUM-CHELATING PEPTIDES AND USES THEREOF
    Publication number: 20180134810
    Abstract: The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence.
    Type: Application
    Filed: March 25, 2016
    Publication date: May 17, 2018
    Inventors: Claudio Vita, Loïc Le Clainche, Véronique Monjardet
  • Uranium-chelating peptides and uses thereof
    Patent number: 9321849
    Abstract: The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence.
    Type: Grant
    Filed: December 28, 2010
    Date of Patent: April 26, 2016
    Assignee: Commissariat a l'Energie Atomique et aux Energies Alternatives
    Inventors: Claudio Vita, Mireille Sauvage-Vita, Fabio Vita, Elena Vita, Loïc Le Clainche, Véronique Monjardet
  • URANIUM-CHELATING PEPTIDES AND USES THEREOF
    Publication number: 20110093964
    Abstract: The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence.
    Type: Application
    Filed: December 28, 2010
    Publication date: April 21, 2011
    Inventors: Claudio Vita, Mireille Sauvage-Vita, Fabio Vita, Elena Vita, Loïc Le Clainche, Véronique Monjardet
  • Uranium-chelating peptides and uses thereof
    Patent number: 7888311
    Abstract: The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence.
    Type: Grant
    Filed: July 1, 2004
    Date of Patent: February 15, 2011
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Claudio Vita, Mireille Sauvage-Vita, legal representative, Fabio Vita, legal representative, Elena Vita, legal representative, Loïc Le Clainche, Véronique Monjardet
  • Uranium-chelating peptides and uses thereof
    Publication number: 20100015056
    Abstract: The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence.
    Type: Application
    Filed: July 1, 2004
    Publication date: January 21, 2010
    Inventors: Claudio Vita, Mireille Sauvage-Vita, Fabio Vita, Elena Vita, Loïc Le Clainche, Véronique Monjardet